Affinity Technologies has appointed J. Michael Edwards as Chief Financial Officer. Takeaway Points bioAffinity Technologies ...

Affinity Technologies today announced it appointed J. Michael Edwards as chief financial officer in September.

Affinity Technologies' CyPath® Lung test will be added to the Federal Supply Schedule to help veterans and active military at ...

More doctors are ordering bioAffinity Technologies' CyPath Lung test and sales are skyrocketing. A long-term military health ...

CyPath Lung is a laboratory-developed assay that uses self-collected sputum samples treated with a fluorescent compound that preferentially binds to cancer cells and cancer-related cells, San ...

SAN ANTONIO, TX – bioAffinity Technologies, Inc. (NASDAQ:BIAF), a commercial physical and biological research services company, announced today that its shareholders have approved the issuance of ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today raised its full-year forecast ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer ...

Noninvasive diagnostic test for lung cancer available to U.S. Veterans, other federal health services patients SAN ANTONIO, October 09, 2024--(BUSINESS WIRE)--bioAffinity Technologies, Inc ...

Edwards will report directly to bioAffinity Technologies President and CEO Maria Zannes. "We are delighted to welcome Michael ...